Erythropoietin as candidate for supportive treatment of severe COVID-19

Title
Erythropoietin as candidate for supportive treatment of severe COVID-19
Authors
Keywords
-
Journal
MOLECULAR MEDICINE
Volume 26, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-17
DOI
10.1186/s10020-020-00186-y

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation